Avid Bioservices Inc (CDMO)
10.34
+0.07
(+0.68%)
USD |
NASDAQ |
Nov 04, 16:00
10.33
-0.01
(-0.10%)
Pre-Market: 20:00
Avid Bioservices Net Income (Annual): -140.75M for April 30, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
April 30, 2024 | -140.75M |
April 30, 2023 | 0.259M |
April 30, 2022 | 127.67M |
April 30, 2021 | 11.21M |
April 30, 2020 | -10.47M |
April 30, 2019 | -4.215M |
April 30, 2018 | -21.81M |
April 30, 2017 | -28.16M |
April 30, 2016 | -55.65M |
April 30, 2015 | -50.36M |
April 30, 2014 | -35.36M |
April 30, 2013 | -29.78M |
April 30, 2012 | -42.12M |
April 30, 2011 | -34.15M |
April 30, 2010 | -14.49M |
Date | Value |
---|---|
April 30, 2009 | -16.52M |
April 30, 2008 | -23.18M |
April 30, 2007 | -20.80M |
April 30, 2006 | -17.06M |
April 30, 2005 | -15.45M |
April 30, 2004 | -14.34M |
April 30, 2003 | -11.56M |
April 30, 2002 | -11.72M |
April 30, 2001 | -9.535M |
April 30, 2000 | -14.51M |
April 30, 1999 | -19.50M |
April 30, 1998 | -11.80M |
April 30, 1997 | -33.20M |
April 30, 1996 | 0.30M |
April 30, 1995 | -6.90M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-140.75M
Minimum
2024
127.67M
Maximum
2022
-2.415M
Average
0.259M
Median
2023
Net Income (Annual) Benchmarks
MEI Pharma Inc | 17.78M |
Altimmune Inc | -88.45M |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -29.74M |
iBio Inc | -24.91M |